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Abstract Rabbit cDNA of the K1 subunit of the skeletal muscle
dihydropyridine (DHP) receptor was functionally expressed in a
muscular dysgenesis mouse (mdg) cell line, GLT. L-type calcium
currents and transients were recorded for the wild type and a
mutant K1 subunit carrying an R528H substitution in the
supposed voltage sensor of the second channel domain that is
linked to a human disease, hypokalemic periodic paralysis. L-
type channels expressed in GLT myotubes exhibited currents
similar to those described for primary cultured mdg cells injected
with rabbit wild type cDNA, indicating this system to be useful
for functional studies of heterologous DHP receptors. Voltage
dependence and kinetics of activation and inactivation of L-type
calcium currents from mutant and wild type channels did not
differ significantly. Intracellular calcium release activation
measured by fura-2 microfluorimetry was not grossly altered
by the mutation either. Analogous measurements on myotubes of
three human R528H carriers revealed calcium transients
comparable to controls while the voltage dependence of both
activation and inactivation of the L-type current showed a shift to
more negative potentials of approximately 6 mV. Similar effects
on the voltage dependence of the fast T-type current and changes
in the expression level of the third-type calcium current point to
factors not primarily associated with the mutation perhaps
participating in disease pathogenesis.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Dihydropyridine (DHP) receptors of skeletal muscle func-
tion as both voltage-gated L-type calcium channels and volt-
age sensors of intracellular calcium release-initiating contrac-
tion [1]. They are composed of ¢ve tightly associated proteins,
K1, K2/N, L1, and Q, encoded by four di¡erent genes [2]. The
K1 subunit is not only the largest of these, but also contains
the ion-conducting pore, DHP binding sites, and putative
voltage-sensitive structures in four transmembrane helices of
four analogous domains, the S4 segments, with an unusually
high density of positively charged residues. While the charges
of domains I and III seem to be important for channel acti-
vation [3], the function of the arginines in repeat II has not
been clari¢ed su⁄ciently. At least mutations of inner arginines
in repeat II do not mediate any detectable parameter change
[3].
The outermost charge in repeat II, R528, is mutated to
histidine in the human disease hypokalemic periodic paralysis
[4], suggesting an important role of this residue for channel
function. While the ¢rst report on DHP receptor-mediated L-
type current in myotubes of an a¡ected patient expressing
both wild type and mutant channels revealed a 36 mV left
shift in steady-state inactivation [5], expression of the rabbit
channel in a ¢broblast cell line showed a reduction of current
density to be the only detectable e¡ect of the amino acid
exchange [6]. Introduction of an R528H equivalent, R650H,
into the human cardiac K1 subunit and expression in human
embryonic kidney cells displayed only barely signi¢cant
changes in voltage dependence of activation and inactivation
of the L-type current [7], leading the authors to conclude that
the cardiac channel may not be an adequate model for e¡ects
of the skeletal DHP receptor mutant.
Proper functional expression of the skeletal muscle K1 sub-
unit demands the co-expression of the other DHP receptor
subunits, the ryanodine receptor and perhaps additional not
yet identi¢ed triad proteins. Therefore, exclusive expression of
R528H in a muscular environment might give a clue to the
real disease pathogenesis. Because they provide the necessary
environment, primary cultured myotubes from mice homozy-
gous for the muscular dysgenesis (mdg) mutation and thus
lacking functional K1 subunits [8] have been frequently used
as expression system for recombinant K1 subunit cDNA. In-
stead of primary cell cultures which require animal mainte-
nance, we successfully employed myotubes derived from a
recently developed mdg cell line, GLT [9], and functionally
characterized this expression system for the ¢rst time. Using
whole cell tight seal recordings and fura-2 micro£uorimetry,
we were able to study not only the L-type current as in the
previous reports on the R528H mutant, but also the voltage
dependence of intracellular calcium release activation, neither
of which has been described for the new cell line or for human
myotubes.
2. Materials and methods
2.1. Mutagenesis
As rabbit and human K1 subunit proteins are 95.5% identical
[10,11] in the physiologically expressed functionable isoform [12]
and functional equivalence may be expected, rabbit cDNA in a
PSG5 vector (Stratagene) was employed for site-directed mutagenesis.
The G1583A cDNA mutation which results in the R528H amino acid
change was introduced using the reverse oligonucleotide 5P-
CGGATGCAGTGCAACACGG-3P and veri¢ed by sequencing [6].
2.2. Cell culture
Myoblasts of an immortalized mdg mouse muscle cell line, GLT [9],
were cultured in a medium consisting of 80% Dulbecco’s modi¢ed
Eagle medium (1 g glucose/l), 10% fetal calf serum, and 10% horse
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serum (all Gibco) in gelatin-coated bottles or dishes at 37‡C and a
CO2 atmosphere of 5%. Serum content was reduced to 2% horse
serum on day 2 after the last passing procedure to induce maturation
and fusion of cells. To optimize the transfection method, we initially
performed all experiments using both LacZ gene and the rabbit
cDNA thus checking e⁄ciency both quantitatively and functionally.
Calcium phosphate precipitation yielded the best transfection rates.
Lipofectamine treatment lead to vacuolization of the cells making
patch-clamping unnecessarily di⁄cult. Functional expression of L-
type currents could be achieved by transfecting on days 6^8, with
the best results on culture day 7, shortly after fusion commenced.
Transfections on days 2^5 before fusion did not allow di¡erentiation,
later myotube fusion or detectable channel expression. To enable de-
tection of cells which had taken up K1 subunit cDNA, cells were co-
transfected with both the PSG5 vector and EBO-pcD-CD8 (Leu2)
containing cDNA of the lymphocyte surface antigen CD8 (T-lympho-
cyte cytotoxic suppressor gene, gift of R.F. Margolskee) in a ratio of
5:1 using the calcium phosphate precipitation method at day 7 after
the last passing step. Successful expression of the marker gene de-
tected by polystyrene microspheres precoated with antibodies to
CD8 [13] indicated candidate cells for patch-clamp experiments.
Human HypoPP myotubes were derived from satellite cells of bi-
opsies from the lateral vastus muscle of patients carrying the R528H
mutation. Control myotubes were obtained from subjects biopsied for
malignant hyperthermia diagnosis and found to be negative in the in
vitro contracture test. All procedures involving human material were
performed in accordance with the Helsinki convention and approved
by the Ethics Commission of the University of Ulm.
Biopsy material was enzymatically dissociated at 37‡C in Hanks’
solution (Biochrom) containing collagenase (250 U/ml, type II, Sigma)
and bactotrypsin (Biochrom). The cells were grown in a 1:1 mixture
of Ham’s F12 and CMRL medium containing 5% horse serum and
5% fetal calf serum (both Biochrom) in a 5% CO2 atmosphere at 37‡C
[5].
2.3. Electrophysiology
Standard whole cell recordings were performed on 8^15 day old
myotubes after partial (30^60%) series resistance compensation using
an Axopatch 200A patch-clamp ampli¢er (Axon Instruments). Volt-
age errors due to series resistances were less than 5 mV for GLT
myotubes and less than 9 mV for human myotubes. The bathing
solution contained (in mM): TEA-Cl 120, CaCl2 10, MgCl2 1,
HEPES 10, glucose 5, 4-aminopyridine (4-AP) 1, EGTA 0.1, tetrodo-
toxin 0.02 (pH 7.4). Pipettes were ¢lled with (in mM): CsCl 130,
MgCl2 0.5, HEPES 10, EGTA 1, Mg-ATP 5, phosphocreatine 5
(pH 7.2). All measurements were performed at room temperature.
Data were ¢ltered at 2 kHz and analyzed using pClamp (Axon Instru-
ments) and Excel (Microsoft).
L-type current activation parameters were obtained from the peak
current-voltage relations I(V) by least square ¢tting of Eq. 1 which
includes a correction term for a linear leak with conductance gleak and
reversal potential Vleak.
IV  gleakUV3Vleak  gmaxUV3VCa=1 expV0:53V=k
1
VCa and gmax are reversal potential and maximum conductance re-
spectively.
For steady-state inactivation, prepulses of 20 s duration to di¡erent
voltages Vpre were applied and the current I(Vpre) which remained
activatable by a subsequent test pulse to 20 mV was normalized by
the current Imax obtained in the absence of a prepulse. I(Vpre)/Imax was
described as Y(V) by Boltzmann functions of the form:
YV  1=1 expV0:53V=k 2
2.4. Calcium transients
Intracellular calcium transient measurements were performed using
a modi¢ed pipette solution containing 100 WM of the penta-potassium
salt of fura-2. Loading times of 5 min were required for the resting
£uorescence of the indicator dye to reach a steady level. Calcium
signals were elicited by step depolarizations. Fluorescence records
were expressed as vF/F (F = £uorescence intensity at 380 nm excita-
tion, vF =3(Ftransient3Fbaseline)). Recordings were made by means of
an inverted microscope equipped for epi-illumination (Axiovert 100,
Zeiss) employing a set of fura-2 ¢lters (emission 510 nm, excitation
380 and 360 nm; Zeiss). The isosbestic wavelength 360 nm was used
for control dye loading. A variable rectangular slit in the emission
pathway mounted in front of the photomultiplier (valve R269, Ha-
mamatsu; gauge MEA1530FK-XV2DN, Seefelder) excluded £uores-
cence from the lumen of the patch pipette. Fluorescence signals were
recorded at a sampling rate of 1 kHz and later digitally ¢ltered with a
Gaussian algorithm at a cut o¡ frequency of 100 Hz. The voltage
dependence of activation A(V) of the calcium signals was also de-
scribed as Y(V) with Eq. 2.
Inactivation of calcium transients was not studied, as it represents a
combination of fura-2 and endogenous calcium bu¡er binding ki-
netics, calcium re-uptake into the sarcoplasmic reticulum, calcium
transport into the extracellular space, and kinetics of ryanodine re-
ceptor inactivation.
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Table 1
Parameters of L-type calcium currents and intracellular calcium transients
WT rabbit cDNA Mutant rabbit cDNA Human control Human HypoPP
Current activation
V0:5 23.1 þ 2.3 mV 20.9 þ 3.4 mV 14.3 þ 0.8 mV 8.6 þ 1.8 mV*
k 36.8 þ 0.5 mV 37.6 þ 0.6 mV 35.9 þ 0.4 mV 36.2 þ 0.4 mV
VCa 70.4 þ 6.9 mV 73.7 þ 6.6 mV 71.0 þ 4.4 mV 66.6 þ 4.4 mV
Umax 33.7 þ 3.2 mV 33.7 þ 3.2 mV 24.3 þ 1.1 mV 18.4 þ 1.8 mV*
Imax 30.9 þ 0.2 pA/pF 31.20 þ 0.3 pA/pF 31.2 þ 0.1 pA/pF 31.6 þ 0.1 pA/pF
Capacitance 315 þ 53 pF 216 þ 64 pF 474 þ 50 pF 433 þ 90 pF
Current density 30.89 þ 0.2 pA/pF 31.2 þ 0.3 pA/pF 31.24 þ 0.1 pA/pF 31.60 þ 0.2 pA/pF
n 7 7 24 26
Inactivation
V0:5 4.2 þ 1.0 mV 3.5 þ 2.7 mV 31.1 þ 1.2 mV 39.4 þ 0.8 mV*
k 6.7 þ 0.6 mV 6.9 þ 0.5 mV 8.1 þ 0.5 mV 9.4 þ 1.1 mV
n 4 4 32 21
Kinetics
dmÿslow 61.9 þ 17.6 ms 51.8 þ 9.3 ms 77.2 þ 9.3 ms 73.3 þ 8.2 ms
dh 5.1 þ 1.1 s 4.1 þ 1.0 s 2.7 þ 0.4 s 2.3 þ 0.4 s
n 4 4 8 12
Ca transient
V0:5 310.5 þ 3.3 mV 315.7 þ 3.5 mV 323.1 þ 1.5 mV 322.0 þ 2.5 mV
k 38.0 þ 1.3 mV 38.1 þ 1.4 mV 38.5 þ 1.1 mV 38.3 þ 0.9 mV
n 13 7 7 6
Signi¢cant di¡erences are marked with an asterisk. Abbreviations: Umax = voltage at current maximum, Imax = current maximum. For further
abbreviations see text.
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Fig. 1. Activation of calcium currents in immortalized mdg (GLT) myotubes (circles) and human myotubes (squares) expressing wild type (¢lled
symbols) or mutant (open) K1 subunits. A: Representative current traces measured in a GLT myotube expressing wild type rabbit K1 subunits
(left) and a normal human myotube (right). Voltage steps were applied from a holding potential of 390 mV to 320 mV and +25 mV respec-
tively. Note the fast low-threshold T-type calcium current and the slow high-threshold L-type current in both myotubes. B: Current traces as
in A, however for mutant (R528H) wild type rabbit K1 subunits (left) and a myotube of a HypoPP patient heterozygous for the R528H muta-
tion (right) showing an incision in the L-type current trace suggesting a third-type current. C: Voltage dependence of activation time constants
dmÿslow for all four cell types: GLT cells on the left (n = 4 each) and human myotubes on the right (control n = 8 and HypoPP n = 12). D: Aver-
age L-type current-voltage relation (means þ S.E.M.) in the GLT myotubes for wild type (¢lled circles) and mutant for n = 7 each on the left,
HypoPP myotubes (n = 26) and human control myotubes (n = 24) on the right. Symbols represent mean of data points, curves are de¢ned by
the mean of the ¢tted parameters (Eq. 1).
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2.5. Statistics
Data are expressed as mean þ S.E.M. Statistical evaluation of di¡er-
ences between wild type and mutant was done using Student’s double-
sided t-test, with P9 0.05 considered signi¢cant.
3. Results
3.1. GLT myotubes expressing normal and mutant rabbit DHP
receptor K1 subunit
The present study is the ¢rst one to make use of the im-
mortalized mdg cell line GLT [9] for functional expression of
recombinant and wild type K1 subunits. Untransfected GLT
myotubes (n = 10) showed no trace of slow high-voltage-acti-
vated calcium inward currents. These, however, were detect-
able after transfection and are therefore considered to be
mediated by the exogenous K1 subunit (Fig. 1A, left). GLT
transfected with R528H K1 cDNA revealed non-signi¢cantly
higher current densities (Table 1) at similar transfection rates
(25% for the mutant and 32% for wild type in a CD8 cell
population) and comparable maximal current amplitudes
(3260 vs. 3280 pA; Fig. 1B, left).
Activation was ¢tted by two exponentials starting 6 ms
after onset of the depolarization to minimize the in£uence
of the fast current components. The time constant for L-
type current activation, dmÿslow, showed considerable variabil-
ity although overall little voltage dependence (Fig. 1C, left).
Even though activation of the mutant channels was slightly
faster on average, values for dmÿslow did not di¡er signi¢cantly
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Fig. 2. Inactivation of calcium currents in GLT (circles) and human myotubes (squares) expressing wild type (¢lled symbols) or mutant (open)
K1 subunits. A: Examples of superimposed current traces at 20 mV normalized to 1 measured in GLT myotubes with wild type and mutant
rabbit K1 subunits (left) as well as in human control and HypoPP myotubes (right) elicited from a holding potential of 390 mV. B: Voltage
dependence of inactivation time constants dh for all four cell types: GLT cells on the left (n = 4 each) and human myotubes on the right (con-
trol n = 8 and HypoPP n = 12). C: Average fractional steady-state inactivation (means þ S.E.M.) in GLT myotubes for wild type and mutant for
n = 4 each on the left, human control (n = 32) and HypoPP myotubes (n = 21) on the right. Curves were calculated with the means of Boltzmann
¢tted parameters (Eq. 2). In addition, the corresponding steady-state activation curves calculated from the data given in Fig. 1C are shown.
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for depolarizing steps to 20 mV, i.e. near the current maxi-
mum (Table 1). Analysis of I-V data (Figs. 1D and 2C, left)
according to Eq. 1 yielded similar best ¢t parameter values for
the two groups (Table 1). Capacitances of cells expressing
R528H mutant channels were by about 30% smaller on aver-
age.
The decay of calcium currents in GLT myotubes was eval-
uated by determining inactivation time constants, dh, in cur-
rent traces of 20 s (Fig. 2A, left). No signi¢cant di¡erence in
kinetics between mutant and wild type could be seen (Fig. 2B,
see also Table 1). Steady-state inactivation curves (Fig. 2C,
left) were essentially identical.
3.2. Human myotubes expressing wild type and mutant DHP
receptor K1 subunit
The similar results on GLT cells for wild type and mutant
channels prompted us to reinvestigate myotubes from healthy
controls and HypoPP patients. Three de¢nitely clinically af-
fected persons were biopsied, two members of family Hy-
poPP19 described in [4], and one of family HypoPP11 de-
scribed in [5]. Myotubes of nine una¡ected individuals were
cultured as controls.
Patients’ myotubes required on average four culture days
longer to obtain currents su⁄cient for measurement (Fig.
1A,B, right). Kinetics of activation and inactivation ¢tted as
described above were not signi¢cantly di¡erent for mutant
and normal L-type currents (Figs. 1B and 2A,B, right; see
also Table 1). Comparing current-voltage relations (Fig.
1D), peak current density did not di¡er signi¢cantly, but the
voltage at which maximum current was reached marginally
did (18.4 vs. 24.3 mV). Of the ¢tted parameters for steady-
state activation and inactivation, the V0:5 values were both
shifted to the left by 6^8 mV (8.6 vs. 14.3 mV, n = 26 and
24, and 39.4 vs. 31.1 mV; Fig. 2C, right). The corresponding
change in reversal potential was not statistically signi¢cant
(Table 1).
In order to determine whether the displacements of the
voltage dependencies were speci¢c for the L-type current, ad-
ditional parameters independent of the DHP receptor were
examined. The percentage of cells expressing both L-type
and fast transient (T-type) calcium currents was similar for
patient and control myotubes (68.8% vs. 67.3%), while a
third-type current ¢rst described by Rivet et al. [14] was dis-
tinguishable in 31.4% of cells of R528H carriers compared to
16.4% in controls. Voltage at current maximum and steady-
state inactivation of the T-type current were signi¢cantly al-
tered in a similar way as the L-type currents: voltage at cur-
rent maximum: 329.0 þ 6.8 mV vs. 325.1 þ 5.8 mV; steady-
state inactivation: V0:5 =355.9 þ 2.4 mV vs. 348.4 þ 2.5 mV,
despite the steepness of the inactivation curve remaining un-
changed: k = 5.1 þ 0.4 mV vs. 4.7 þ 0.7 mV (n = 16 and 14,
respectively).
3.3. Calcium transients in GLT and human myotubes
L-type current amplitude was reduced by the dye-contain-
ing pipette solution so that a second set of cells was required
for calcium transient measurements. The voltage protocol
consisted of rectangular pulses from the holding potential of
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Fig. 3. Calcium transients in GLT and human myotubes. A: Average traces (n = 8) of calcium transients at 20 mV elicited from a holding po-
tential of 390 mV and normalized to 1 for wild type and mutant rabbit channels expressed in GLT myotubes (on the left) as well as for nor-
mal control and HypoPP myotubes (on the right). B: Means of the transient steady-state ratios (means þ S.E.M.) in the GLT myotubes for
wild type (¢lled circles, n = 13) and mutant (open circles, n = 7) on the left, hypokalemic periodic paralysis myotubes (open squares, n = 6) and
una¡ected controls (¢lled squares, n = 7) on the right. Curves represent means of the Boltzmann ¢tted parameters.
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390 mV to the test potentials from 360 mV to +40 mV.
Neither depolarizing prepulses nor addition of heavy metal
ions were applied to block T-type current in£uence in an
e¡ort to minimize possible e¡ects on the dihydropyridine re-
ceptor by partial inactivation and change of super¢cial charge
density. At membrane potentials where T currents were max-
imal, the £uorescence signal was small and no correlation
could be seen between the size of the T current and the size
of the £uorescence signal, thus justifying this procedure.
Fig. 3A shows the ratio 3vF/F at 380 nm excitation (see
Section 2) resulting from calcium release for GLT (left) and
human myotubes (right) for depolarizing voltage steps from
390 mV to +20 mV. Maxima (average of last 20 points) for
each depolarizing step were plotted against voltage and ¢tted
with a Boltzmann relation (Eq. 2). When comparing the acti-
vation parameters for calcium transients (Fig. 3B) with those
of calcium conductance (Table 1) it becomes obvious that
calcium release is activated at about 35 mV more negative
potentials (V0:5). However, a signi¢cant di¡erence between
wild type and mutant could be detected neither in V0:5 nor
in k Boltzmann ¢t (Table 1).
4. Discussion
4.1. Calcium transients and currents of heterologously
expressed DHP receptors
Attempts to utilize an immortalized mdg cell line for func-
tional expression of skeletal muscle DHP receptors have failed
in the past, presumably due to lack of fusion of precursor cells
to myotubes [15]. Transfection had previously been performed
directly before myotube fusion corresponding to culture days
4 and 5 in our cell system, a time point at which GLT, too,
did not display the ability to fuse and to express detectable L-
type currents. The decisive criterion for expression therefore
may well be the time point of transfection, which was most
successful on day 7 of culture, i.e. shortly after fusion com-
mences.
Whole cell L-type currents in transfected GLT cells re-
sembled those in primary dysgenic myotubes injected with
cDNA of the rabbit channel showing similar voltage depend-
ence of gating (activation: V0:5 = 24 mV, k =38.2 mV accord-
ing to [16]. Also, our average current density and thus channel
density for wild type channels was within the range described
for injected primary mdg cultures and our rather high dmÿslow
corresponded to the negative linear relationship between these
two parameters described by [17]. Judging by this, the struc-
tural and functional equivalence of our system to primary
mdg seems con¢rmed, although the expression levels clearly
ranged at the lower end of those for the primary myotubes.
Calcium transients in transfected GLT activated at 33 mV
more negative potentials than in injected primary mdg cul-
tures (18 mV [16]) while the voltage dependence of current
conductance was similar. This may be due to an unusually
high intracellular concentration of 5 mM free Mg2 (as
5 mM MgCl2) and absence of ATP in the solution used by
[16] possibly rendering the ryanodine receptor less sensitive to
voltage changes. Our solution contained 0.5 mM MgCl2 and
5 mM MgATP resulting in approximately 1 mM free Mg2,
i.e. near physiological values.
4.2. Mutant DHP receptors
Residue R528 of the K1 subunit, mutated in the human
disease hypokalemic periodic paralysis [4], would be expected
to play an important role in channel function. Because of the
location of the mutation in one of the putative voltage-sensing
regions (S4), we focused on three voltage-dependent gating
processes attributed to the DHP receptor, i.e. activation and
inactivation of the slow (L-type) calcium conductance and the
activation of calcium release. Surprisingly, no clear e¡ect on
gating by the R528H mutation could be detected in the GLT
cells. Also, expression of both mutant and wild type rabbit
channels seemed comparable as judged by current densities
and transfection rates. The fact that Lapie et al. [6] found a
current density reduction of almost 70% using the same con-
struct in a ¢broblast cell line may well be dependent on the
expression system employed, as other characteristics such as
the voltage dependence of gating also deviated clearly from
the results of Garcia et al. [16] and our own. It seems unlikely
that reduction of current density should be the pathogenetic
e¡ect in hypokalemic periodic paralysis, as strength is not
reduced in mice heterozygous for the mdg frame shift muta-
tion nor do elderly human beings show paralytic attacks de-
spite the reduction of DHP receptor expression down to 50%
[18]. Also, the dominant mode of inheritance of the disease
suggests a change of function by the mutation rather than a
loss of function.
In human myotubes, a slight but systematic voltage shift of
about 36 mV in activation and inactivation of both L-type
and T-type currents was found. The twofold overexpression of
the third-type calcium current, perhaps compensating a very
slight L-type channel de¢ciency, implies a change in protein
expression patterns. If such changes a¡ected for example aux-
iliary K2/N or L1 subunit expression crucial for voltage de-
pendence of gating, they could well account for the above
observations [19]. As the time point of introduction of the
K1 subunit a¡ects di¡erentiation and fusion behavior of the
myotubes, demonstrated by our experiments on GLT, the
presence of the mutation in early stages of development in
human cells may well change di¡erentiation processes and
protein expression patterns from the start.
Sipos et al. [5] reported a left shift of over 30 mV in L-type
current steady-state inactivation in four myotubes of a single
R528H carrier. Our present results in 26 steady-state inacti-
vation measurements in myotubes of three a¡ected carriers
(including the father of the patient examined in [5]) using
identical culture conditions, pipette and bath solutions fail
to con¢rm this. Re-evaluation of the data given in [5] revealed
the apparent employment of an incorrect calculation algo-
rithm and the true parameters of steady-state inactivation of
the mutant vs. wild type to be 35.5 þ 11.2 mV vs. 34.9 þ 4.3
mV and k = 8.3 þ 2.0 mV vs. 8.8 þ 1.3 mV. Due to the large
standard deviation and so few measurements (V0:5 ranged
from 321.55 mV to +2.75 mV for measurements of the mu-
tant), the slight negative shift of 6 mV is not detectable in that
data set (Sipos et al., in preparation).
Voltage-sensing S4 segments are thought to move outward
during membrane depolarization. While single deletions of
positively charged residues of IS4 and IIIS4 are su⁄cient to
signi¢cantly a¡ect voltage dependence of L-type current acti-
vation, this is not the case for inner charge deletions of IIS4
[3]. Stuºhmer et al. [20] introduced double deletions of these
charges in IIS4 before achieving a detectable e¡ect in the
analogous sodium channel K subunit. Perhaps the R528H
mutation indeed is not su⁄cient to disturb current activation
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decisively, leaving a possible in£uence on calcium release to
account for the pathogenesis of the weakness attacks observed
in hypokalemic periodic paralysis patients. This would agree
with Lerche et al. [7] who found no appreciable change in
gating of an analogous mutation, R650H, in the cardiac chan-
nel. As calcium transients had not been measured before, the
present study is the ¢rst to describe these. Lack of a clear
e¡ect in our measurements may indicate that more subtle
functional changes account for disease pathogenesis. Secon-
dary to the mutation, changes in expression patterns of chan-
nel subunits or regulatory proteins as suggested by the alter-
ations in T-type and third-type calcium currents may be an
important factor leading to the muscle cell membrane depola-
rization associated with the paralytic attacks in patients.
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